|
JPS5522636A
(en)
*
|
1978-08-04 |
1980-02-18 |
Takeda Chem Ind Ltd |
Thiazoliding derivative
|
|
JPS5697277A
(en)
*
|
1980-01-07 |
1981-08-05 |
Takeda Chem Ind Ltd |
Thiazolidine derivative
|
|
AU6610081A
(en)
*
|
1980-01-24 |
1981-07-30 |
Senju Pharmaceutical Co., Ltd. |
Thiazolidine derivatives
|
|
JPS58118577A
(ja)
*
|
1982-01-07 |
1983-07-14 |
Takeda Chem Ind Ltd |
チアゾリジン誘導体
|
|
JPS6051189A
(ja)
*
|
1983-08-30 |
1985-03-22 |
Sankyo Co Ltd |
チアゾリジン誘導体およびその製造法
|
|
WO1985004170A1
(fr)
*
|
1984-03-21 |
1985-09-26 |
Takeda Chemical Industries, Ltd. |
Derives de thiazolidinedione, leur procede de preparation et compositions medicinales les contenant
|
|
US4582839A
(en)
*
|
1984-03-21 |
1986-04-15 |
Takeda Chemical Industries, Ltd. |
2,4-thiazolidinediones
|
|
JPS6143114A
(ja)
*
|
1984-08-03 |
1986-03-01 |
Takeda Chem Ind Ltd |
虹彩・毛様体疾患治療用眼局所投与剤
|
|
CN1003445B
(zh)
*
|
1984-10-03 |
1989-03-01 |
武田药品工业株式会社 |
噻唑烷二酮衍生物,其制备方法和用途
|
|
WO1986002073A1
(fr)
*
|
1984-10-03 |
1986-04-10 |
Takeda Chemical Industries, Ltd. |
Derives de thiazolidinedione, procede de preparation et composition pharmaceutique les contenant
|
|
AR240698A1
(es)
*
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
|
DK173350B1
(da)
|
1985-02-26 |
2000-08-07 |
Sankyo Co |
Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
|
|
US4703052A
(en)
*
|
1985-05-21 |
1987-10-27 |
Pfizer Inc. |
Hypoglycemic thiazolidinediones
|
|
US4738972A
(en)
*
|
1985-05-21 |
1988-04-19 |
Pfizer Inc. |
Hypoglycemic thiazolidinediones
|
|
JPH06779B2
(ja)
*
|
1985-06-10 |
1994-01-05 |
武田薬品工業株式会社 |
チアゾリジオン誘導体およびそれを含んでなる医薬組成物
|
|
US5356917A
(en)
*
|
1985-08-09 |
1994-10-18 |
Eli Lilly And Company |
Aryl-substituted rhodanine derivatives
|
|
US5691367A
(en)
*
|
1985-08-09 |
1997-11-25 |
Eli Lilly And Company |
Aryl-substituted rhodanine derivatives
|
|
GB8528633D0
(en)
*
|
1985-11-21 |
1985-12-24 |
Beecham Group Plc |
Compounds
|
|
US4873255A
(en)
*
|
1987-02-04 |
1989-10-10 |
Sankyo Company Limited |
Thiazolidinone derivatives, their preparation and their use
|
|
JPS63230689A
(ja)
*
|
1987-03-18 |
1988-09-27 |
Tanabe Seiyaku Co Ltd |
ベンゾオキサジン誘導体
|
|
US4968707A
(en)
*
|
1987-06-10 |
1990-11-06 |
Pfizer Inc. |
Oxazolidin-2-one derivatives as hypoglycemic agents
|
|
EP0295828A1
(en)
*
|
1987-06-13 |
1988-12-21 |
Beecham Group Plc |
Novel compounds
|
|
EP0842925A1
(en)
*
|
1987-09-04 |
1998-05-20 |
Beecham Group Plc |
Substituted thiazolidinedione derivatives
|
|
US5521201A
(en)
*
|
1987-09-04 |
1996-05-28 |
Beecham Group P.L.C. |
Method for treatment of atherosclerosis
|
|
US4791125A
(en)
*
|
1987-12-02 |
1988-12-13 |
Pfizer Inc. |
Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
|
|
US4798835A
(en)
*
|
1987-12-02 |
1989-01-17 |
Pfizer Inc. |
dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent
|
|
US5223522A
(en)
*
|
1988-03-08 |
1993-06-29 |
Pfizer Inc. |
Thiazolidinedione hypoglycemic agents
|
|
WO1989008651A1
(en)
*
|
1988-03-08 |
1989-09-21 |
Pfizer Inc. |
Hypoglycemic thiazolidinedione derivatives
|
|
US5130379A
(en)
*
|
1988-03-08 |
1992-07-14 |
Pfizer Inc. |
Hypoglycemic thiazolidinedione derivatives
|
|
US5120754A
(en)
*
|
1988-03-08 |
1992-06-09 |
Pfizer Inc. |
Thiazolidinedione hypoglycemic agents
|
|
US5330998A
(en)
*
|
1988-03-08 |
1994-07-19 |
Pfizer Inc. |
Thiazolidinedione derivatives as hypoglycemic agents
|
|
US5061717A
(en)
*
|
1988-03-08 |
1991-10-29 |
Pfizer Inc. |
Thiazolidinedione hypoglycemic agents
|
|
GB8820389D0
(en)
*
|
1988-08-26 |
1988-09-28 |
Beecham Group Plc |
Novel compounds
|
|
GB8919417D0
(en)
|
1989-08-25 |
1989-10-11 |
Beecham Group Plc |
Novel compounds
|
|
US5053420A
(en)
*
|
1989-10-13 |
1991-10-01 |
Pershadsingh Harrihar A |
Thiazolidine derivatives for the treatment of hypertension
|
|
WO1991007107A1
(en)
*
|
1989-11-13 |
1991-05-30 |
Pfizer Inc. |
Oxazolidinedione hypoglycemic agents
|
|
US5036079A
(en)
*
|
1989-12-07 |
1991-07-30 |
Pfizer Inc. |
Hypoglycemic thiazolidinedione derivatives
|
|
US5216002A
(en)
*
|
1989-12-21 |
1993-06-01 |
Eli Lilly And Company |
Method of treating inflammatory bowel disease
|
|
US5143930A
(en)
*
|
1990-02-07 |
1992-09-01 |
Sankyo Company, Limited |
Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
|
|
JP3544659B2
(ja)
*
|
1990-02-09 |
2004-07-21 |
ファルマシア・アンド・アップジョン・カンパニー |
インスリン感性化剤類の高血圧治療のための使用
|
|
US5356913A
(en)
*
|
1990-02-09 |
1994-10-18 |
The Upjohn Company |
Use of insulin sensitizing agents to treat hypertension
|
|
ATE205206T1
(de)
*
|
1990-04-27 |
2001-09-15 |
Sankyo Co |
Benzylidenthiazolidinderivate, ihre herstellung und ihre anwendung als lipidperoxid-inhibitoren
|
|
US5037842A
(en)
*
|
1990-06-05 |
1991-08-06 |
Pfizer Inc. |
Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents
|
|
US5089514A
(en)
*
|
1990-06-14 |
1992-02-18 |
Pfizer Inc. |
3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
|
|
ES2067945T3
(es)
*
|
1990-08-23 |
1995-04-01 |
Pfizer |
Derivados de hidroxiurea hipoglicemica.
|
|
GB9023585D0
(en)
*
|
1990-10-30 |
1990-12-12 |
Beecham Group Plc |
Novel compounds
|
|
GB9023584D0
(en)
*
|
1990-10-30 |
1990-12-12 |
Beecham Group Plc |
Novel compounds
|
|
JPH04210683A
(ja)
*
|
1990-12-06 |
1992-07-31 |
Terumo Corp |
チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
|
|
US5158966A
(en)
*
|
1991-02-22 |
1992-10-27 |
The University Of Colorado Foundation, Inc. |
Method of treating type i diabetes
|
|
JP3053490B2
(ja)
*
|
1991-02-25 |
2000-06-19 |
杏林製薬株式会社 |
チアゾリジン−2,4−ジオン誘導体とその塩及び製造法
|
|
US5183823A
(en)
*
|
1991-04-11 |
1993-02-02 |
Takeda Chemical Industries, Ltd. |
Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
|
|
US5441971A
(en)
*
|
1991-04-11 |
1995-08-15 |
The Upjohn Company |
Thiazolidinedione derivatives, production and use thereof
|
|
EP0579733B1
(en)
*
|
1991-04-11 |
2001-06-20 |
PHARMACIA & UPJOHN COMPANY |
Thiazolidinedione derivatives, production and use thereof
|
|
TW222626B
(enExample)
|
1991-07-22 |
1994-04-21 |
Pfizer |
|
|
FR2680512B1
(fr)
*
|
1991-08-20 |
1995-01-20 |
Adir |
Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
|
GB9124513D0
(en)
*
|
1991-11-19 |
1992-01-08 |
Smithkline Beecham Plc |
Novel process
|
|
NO302519B1
(no)
*
|
1991-12-26 |
1998-03-16 |
Sankyo Co |
Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
|
|
NO302471B1
(no)
*
|
1991-12-26 |
1998-03-09 |
Sankyo Co |
Tiazolidinforbindelser og farmasöytisk preparat
|
|
US5498621A
(en)
*
|
1992-05-01 |
1996-03-12 |
Pfizer Inc. |
Oxazolidinedione hypoglycemic agents
|
|
ATE185564T1
(de)
*
|
1992-08-31 |
1999-10-15 |
Sankyo Co |
Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung
|
|
IL106877A
(en)
*
|
1992-09-10 |
1998-03-10 |
Lilly Co Eli |
Rhodanine derivatives for use as medicaments for the treatment of alzheimer's disease
|
|
FR2696743B1
(fr)
*
|
1992-10-12 |
1994-12-23 |
Adir |
Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant.
|
|
TW245716B
(enExample)
*
|
1992-12-28 |
1995-04-21 |
Takeda Pharm Industry Co |
|
|
US5591862A
(en)
*
|
1993-06-11 |
1997-01-07 |
Takeda Chemical Industries, Ltd. |
Tetrazole derivatives, their production and use
|
|
USRE39384E1
(en)
|
1993-09-01 |
2006-11-07 |
Smithkline Beecham P.L.C. |
Substituted thiazolidinedione derivatives
|
|
US6046222A
(en)
*
|
1993-09-15 |
2000-04-04 |
Warner-Lambert Company |
Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
|
|
US5457109A
(en)
*
|
1993-09-15 |
1995-10-10 |
Warner-Lambert Company |
Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
|
|
US5874454A
(en)
*
|
1993-09-15 |
1999-02-23 |
Warner-Lambert Company |
Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
|
|
HU228260B1
(en)
*
|
1993-09-15 |
2013-02-28 |
Daiichi Sankyo Company |
Pharmaceutical compositions to treat impaired glucose tolerance
|
|
AU749416B2
(en)
*
|
1993-09-15 |
2002-06-27 |
Daiichi Sankyo Company, Limited |
Use of thiazolidinediones to prevent or delay onset of NIDDM
|
|
US5401761A
(en)
*
|
1993-12-09 |
1995-03-28 |
Pfizer, Inc. |
Thiazolidinedione hypoglycemic agents
|
|
US6251928B1
(en)
*
|
1994-03-16 |
2001-06-26 |
Eli Lilly And Company |
Treatment of alzheimer's disease employing inhibitors of cathepsin D
|
|
NO303782B1
(no)
*
|
1994-03-23 |
1998-08-31 |
Sankyo Co |
Tiazolidin- og oksazolidinderivater og farmas°ytiske preparater inneholdende slike, samt deres anvendelse til fremstilling av medikamenter
|
|
CA2146701A1
(en)
*
|
1994-04-11 |
1995-10-12 |
Takashi Fujita |
Heterocyclic compounds having anti-diabetic activity, their preparation and their use
|
|
US5594015A
(en)
*
|
1994-06-22 |
1997-01-14 |
Regents Of The University Of California |
Thiazolidine derivatives for the treatment of psoriasis
|
|
US5703096A
(en)
*
|
1994-10-07 |
1997-12-30 |
Sankyo Company, Limited |
Oxime derivatives, their preparation and their therapeutic use
|
|
US5925656A
(en)
*
|
1995-04-10 |
1999-07-20 |
Dr. Reddy's Research Foundation |
Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
|
US5708012A
(en)
*
|
1995-04-28 |
1998-01-13 |
Sankyo Company, Limited |
Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
|
|
CZ293016B6
(cs)
*
|
1995-06-01 |
2004-01-14 |
Sankyo Company Limited |
Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
|
|
JPH09136877A
(ja)
*
|
1995-06-16 |
1997-05-27 |
Takeda Chem Ind Ltd |
複素環化合物、その製造法及び用途
|
|
TWI238064B
(en)
|
1995-06-20 |
2005-08-21 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
|
HUP9601808A3
(en)
*
|
1995-07-03 |
2000-06-28 |
Sankyo Co |
Treatment of arteriosclerosis and xanthoma
|
|
AU7604596A
(en)
*
|
1995-11-17 |
1997-06-11 |
Warner-Lambert Company |
A method of treating myotonic dystrophy
|
|
GB9604242D0
(en)
|
1996-02-28 |
1996-05-01 |
Glaxo Wellcome Inc |
Chemical compounds
|
|
IL120443A
(en)
*
|
1996-03-18 |
2000-07-16 |
Sankyo Co |
Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
|
|
JPH09323930A
(ja)
*
|
1996-04-04 |
1997-12-16 |
Takeda Chem Ind Ltd |
悪液質の予防・治療剤
|
|
DE69725585T2
(de)
*
|
1996-04-04 |
2004-07-01 |
Sankyo Co., Ltd. |
Phenylalkylcarbonsäure-derivate
|
|
US5801173A
(en)
*
|
1996-05-06 |
1998-09-01 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
|
US5919782A
(en)
*
|
1996-05-06 |
1999-07-06 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
|
US5889025A
(en)
*
|
1996-05-06 |
1999-03-30 |
Reddy's Research Foundation |
Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
|
ZA973848B
(en)
*
|
1996-05-06 |
1997-12-02 |
Reddy Research Foundation |
Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
|
|
CA2257284C
(en)
*
|
1996-05-31 |
2005-10-04 |
Sankyo Company Limited |
Remedy for autoimmune diseases
|
|
FR2749583B1
(fr)
|
1996-06-07 |
1998-08-21 |
Lipha |
Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
|
|
AU744518B2
(en)
*
|
1996-07-01 |
2002-02-28 |
Dr. Reddy's Laboratories Limited |
Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
|
US6372750B2
(en)
|
1996-07-01 |
2002-04-16 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
|
|
US5885997A
(en)
*
|
1996-07-01 |
1999-03-23 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
|
US6114526A
(en)
|
1996-07-01 |
2000-09-05 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
|
USRE39266E1
(en)
|
1996-07-01 |
2006-09-05 |
Dr. Reddy's Laboratories, Limited |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
|
CN1221417A
(zh)
*
|
1996-07-26 |
1999-06-30 |
雷迪博士研究基金会 |
具有抗糖尿病、降低血脂、抗高血压性能的噻唑烷二酮化合物,其制备方法及其药物组合物
|
|
US5814647A
(en)
|
1997-03-04 |
1998-09-29 |
Board Of Regents, The University Of Texas System |
Use of troglitazone and related compounds for the treatment of the climacteric symptoms
|
|
JP2001514663A
(ja)
*
|
1997-03-12 |
2001-09-11 |
エスモンド,ロバート ダブリュー. |
アルツハイマー病を処置または予防するための方法
|
|
DE19711617A1
(de)
*
|
1997-03-20 |
1998-09-24 |
Boehringer Mannheim Gmbh |
Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
|
SE9702305D0
(sv)
*
|
1997-06-17 |
1997-06-17 |
Astra Ab |
New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
|
|
CN1114404C
(zh)
*
|
1997-06-18 |
2003-07-16 |
史密丝克莱恩比彻姆有限公司 |
用噻唑烷二酮和二甲双胍治疗糖尿病
|
|
CA2294385C
(en)
*
|
1997-06-18 |
2007-06-05 |
Smithkline Beecham P.L.C. |
Treatment of diabetes with thiazolidinedione and sulphonylurea
|
|
GB9715295D0
(en)
*
|
1997-07-18 |
1997-09-24 |
Smithkline Beecham Plc |
Novel method of treatment
|
|
GB9715306D0
(en)
*
|
1997-07-18 |
1997-09-24 |
Smithkline Beecham Plc |
Novel method of treatment
|
|
BR9813019A
(pt)
|
1997-10-02 |
2000-09-05 |
Sankyo Co |
Derivados do ácido amidocarboxìlico, agentes para diminuir a glicose do sangue, redutor de lipìdio, para melhorar a resistência à insulina, anti-inflamatório, para imuno regulagem, para inibir a aldose reductase, para inibir a 5-lipoxigenase, para a geração de supressor de peróxido de lipìdio, para ativar a ppar, para minorar a osteoporose, e, composições para a terapia ou prevenção da diabete melito, da hiperlipemia, da obesidade, da tolerância à glicose prejudicada, da resistência à insulina que não a igt, do fìgado gorduroso, de complicações diabéticas, da arterioesclerose, da diabete melito gestacional, da sìndrome do ovário policìstico, da artroesteìte, da artrite reumática, de doenças alérgicas, da asma, do câncer, de doenças auto imunes, da pancreatite, e de cataratas
|
|
US7091359B2
(en)
|
1997-11-04 |
2006-08-15 |
Smithkline Beecham Plc |
Process for the preparation of thiazolidinedione derivatives
|
|
GB9723295D0
(en)
|
1997-11-04 |
1998-01-07 |
Smithkline Beecham Plc |
Novel process
|
|
HUP9902721A2
(hu)
|
1997-11-25 |
1999-12-28 |
The Procter & Gamble Co. |
Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
|
|
US20040058873A1
(en)
*
|
1998-03-12 |
2004-03-25 |
Esmond Robert W. |
Method for treating or preventing Alzheimer's disease
|
|
GB9824893D0
(en)
*
|
1998-11-12 |
1999-01-06 |
Smithkline Beckman Corp |
Novel method of treatment
|
|
AR023700A1
(es)
|
1998-11-12 |
2002-09-04 |
Smithkline Beecham Plc |
Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
|
|
WO2000028989A1
(en)
|
1998-11-12 |
2000-05-25 |
Smithkline Beecham P.L.C. |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
|
|
AU1740900A
(en)
*
|
1998-11-20 |
2000-06-13 |
Genentech Inc. |
Method of inhibiting angiogenesis
|
|
US6191154B1
(en)
|
1998-11-27 |
2001-02-20 |
Case Western Reserve University |
Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
|
|
US5968960A
(en)
*
|
1999-01-14 |
1999-10-19 |
The Regents Of The University Of California |
Use of thiazolidinediones to ameliorate the adverse consequences of myocardial ischemia on myocardial function and metabolism
|
|
AU3073700A
(en)
*
|
1999-01-19 |
2000-08-07 |
Sankyo Company Limited |
Troglitazone-containing medicinal compositions for inhibiting apoptosis
|
|
US6204288B1
(en)
|
1999-03-08 |
2001-03-20 |
The University Of Mississippi |
1,2-dithiolane derivatives
|
|
US6127394A
(en)
*
|
1999-03-08 |
2000-10-03 |
The University Of Mississippi |
1,2-Dithiolane derivatives
|
|
CN1329359C
(zh)
|
1999-04-01 |
2007-08-01 |
埃斯佩里安医疗公司 |
醚化合物,及其组合物和用途
|
|
US6214842B1
(en)
|
1999-05-12 |
2001-04-10 |
Michael S. Malamas |
Amino-thiazolidinediones useful in the treatment of insulin resistance and hyperglycemia
|
|
CA2377246A1
(en)
*
|
1999-06-18 |
2000-12-28 |
Ranjit C. Desai |
Arylthiazolidinedione and aryloxazolidinedione derivatives
|
|
JP2001072592A
(ja)
|
1999-07-01 |
2001-03-21 |
Kyowa Hakko Kogyo Co Ltd |
テロメラーゼ阻害剤
|
|
WO2001002377A1
(en)
*
|
1999-07-01 |
2001-01-11 |
Geron Corporation |
Telomerase inhibitors and methods of their use
|
|
US6878749B2
(en)
*
|
1999-09-17 |
2005-04-12 |
Novartis Ag |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
|
US6559188B1
(en)
|
1999-09-17 |
2003-05-06 |
Novartis Ag |
Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
|
|
CO5200844A1
(es)
|
1999-09-17 |
2002-09-27 |
Novartis Ag |
Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes
|
|
US20040266834A1
(en)
*
|
1999-10-14 |
2004-12-30 |
Copland John A. |
Thiazolidinediones alone or in cabination with other therapeutic agents for cancer therapy
|
|
US7323496B2
(en)
*
|
1999-11-08 |
2008-01-29 |
Theracos, Inc. |
Compounds for treatment of inflammation, diabetes and related disorders
|
|
US20080108825A1
(en)
*
|
1999-11-08 |
2008-05-08 |
Theracos, Inc. |
Compounds for treatment of inflammation, diabetes and related disorders
|
|
WO2001052789A2
(en)
|
2000-01-20 |
2001-07-26 |
The Brigham And Women's Hospital, Inc. |
PAX8-PPARη NUCLEIC ACID MOLECULES AND POLYPEPTIDES AND USES THEREOF
|
|
DK1248604T4
(da)
|
2000-01-21 |
2012-05-21 |
Novartis Ag |
Kombinationer indeholdende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler
|
|
US20080103302A1
(en)
*
|
2000-02-04 |
2008-05-01 |
Theracos, Inc. |
Compounds for treatment of inflammation, diabetes and related disorders
|
|
US6680387B2
(en)
*
|
2000-04-24 |
2004-01-20 |
Aryx Therapeutics |
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
|
|
US6958355B2
(en)
*
|
2000-04-24 |
2005-10-25 |
Aryx Therapeutics, Inc. |
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
|
|
US6784199B2
(en)
|
2000-09-21 |
2004-08-31 |
Aryx Therapeutics |
Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals
|
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
|
US7304093B2
(en)
*
|
2000-10-11 |
2007-12-04 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
MXPA03003021A
(es)
|
2000-10-11 |
2003-07-14 |
Esperion Therapeutics Inc |
Compuestos de eter y composiciones para el control del colesterol y usos relacionados.
|
|
WO2002030884A2
(en)
|
2000-10-11 |
2002-04-18 |
Esperion Therapeutics, Inc. |
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
|
|
MXPA03003024A
(es)
|
2000-10-11 |
2003-07-14 |
Esperion Therapeutics Inc |
Compuestos de sulfoxido y bis-sulfoxido y composiciones para el control de colesterol y usos relacionados.
|
|
US6699910B2
(en)
|
2000-10-11 |
2004-03-02 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
US20040122091A1
(en)
*
|
2000-10-11 |
2004-06-24 |
Esperion Therapeutics, Inc. |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
|
US6452014B1
(en)
|
2000-12-22 |
2002-09-17 |
Geron Corporation |
Telomerase inhibitors and methods of their use
|
|
AU2002254940A1
(en)
*
|
2001-03-12 |
2002-09-24 |
Novartis Pharma Gmbh |
Combination of nateglinide or repaglinide with at least one further antidiabetic compound
|
|
US20060047000A1
(en)
*
|
2001-04-24 |
2006-03-02 |
Aryx Therapeutics, Inc. |
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
|
|
JP4152641B2
(ja)
*
|
2001-08-07 |
2008-09-17 |
クラシエ製薬株式会社 |
チアゾリジン誘導体の副作用軽減剤
|
|
US20040204502A1
(en)
*
|
2001-10-11 |
2004-10-14 |
Dasseux Jean-Louis Henri |
Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
|
|
US20050020694A1
(en)
*
|
2001-10-11 |
2005-01-27 |
Dasseux Jean-Louis Henri |
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
|
|
US20040192771A1
(en)
*
|
2001-10-11 |
2004-09-30 |
Dasseux Jean-Louis Henri |
Ether compounds and compositions for cholesterol management and related uses
|
|
ITRM20020016A1
(it)
*
|
2002-01-15 |
2003-07-15 |
Sigma Tau Ind Farmaceuti |
Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
|
|
BR0309152A
(pt)
*
|
2002-04-10 |
2007-01-30 |
Esperion Therapeutics Inc |
composto ou sais, solvatos, hidratos ou pró-drogas deste farmaceuticamente aceitáveis, composição, métodos para tratar ou prevenir uma doença ou condição, uma doença cardiovascular, uma dislipidemia, a hipertensão, o cáncer, a inflamação, e a impotência em um paciente, forma de dosagem unitária, e, método para identificar um composto útil para tratar ou prevenir uma condição em um paciente
|
|
WO2004004774A2
(en)
*
|
2002-07-03 |
2004-01-15 |
Esperion Therapeutics, Inc. |
Compositions comprising panthetine for the treatment of dyslipidemia
|
|
ATE372336T1
(de)
*
|
2002-07-16 |
2007-09-15 |
Cadila Healthcare Ltd |
Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
|
|
US8993773B2
(en)
|
2002-07-16 |
2015-03-31 |
Cadila Healthcare Limited |
Process to prepare pioglitazone via several novel intermediates
|
|
US8268352B2
(en)
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
|
US8216609B2
(en)
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
|
US20040048910A1
(en)
*
|
2002-08-22 |
2004-03-11 |
Bove Susan Elizabeth |
Method of treating osteoarthritis
|
|
BRPI0318046B8
(pt)
*
|
2003-01-23 |
2021-05-25 |
Esperion Therapeutics Inc |
compostos de hidroxila, seu usos, e composições farmacêuticas
|
|
WO2004100895A2
(en)
*
|
2003-05-13 |
2004-11-25 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a peroxisome proliferator activated receptor agonist for the treatment of ischemic mediated central nervous system disorders
|
|
US7230016B2
(en)
*
|
2003-05-13 |
2007-06-12 |
Synthon Ip Inc. |
Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
|
|
WO2004101560A1
(en)
*
|
2003-05-13 |
2004-11-25 |
Synthon B.V. |
Processes for making thiazolidinedione derivatives and compounds thereof
|
|
SG141430A1
(en)
*
|
2003-05-30 |
2008-04-28 |
Ranbaxy Lab Ltd |
Substituted pyrrole derivatives and their use as hmg-co inhibitors
|
|
WO2005002557A1
(en)
*
|
2003-07-03 |
2005-01-13 |
Warner-Lambert Company Llc |
Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof
|
|
JP4839221B2
(ja)
*
|
2003-11-07 |
2011-12-21 |
ジェイ ジェイ ファーマ,インコーポレイテッド |
Hdlを高める併用療法用複合物
|
|
US20050192347A1
(en)
*
|
2003-12-23 |
2005-09-01 |
Dasseux Jean-Louis H. |
Urea and thiourea compounds and compositions for cholesterol management and related uses
|
|
EP1701931B1
(en)
|
2003-12-24 |
2018-10-10 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
EP1716144A2
(en)
*
|
2004-02-20 |
2006-11-02 |
Synthon B.V. |
Processes for making pioglitazone and compounds of the processes
|
|
US7161756B2
(en)
*
|
2004-05-10 |
2007-01-09 |
Tandberg Data Storage Asa |
Method and system for communication between a tape drive and an external device
|
|
CA2568394A1
(en)
*
|
2004-06-09 |
2005-12-29 |
Avanir Pharmaceuticals |
Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
|
|
TW200603794A
(en)
*
|
2004-06-09 |
2006-02-01 |
Avanir Pharmaceuticals |
Small molecules for treatment of hypercholesterolemia and related diseases
|
|
JP2008509228A
(ja)
*
|
2004-06-09 |
2008-03-27 |
アバニール・ファーマシューティカルズ |
高コレステロール血症の治療のための逆コレステロール輸送のメディエイタ
|
|
US20070269486A1
(en)
*
|
2005-03-14 |
2007-11-22 |
Conor Medsystems, Llc. |
Methods and Devices for Reducing Tissue Damage After Ischemic Injury
|
|
BRPI0618379A2
(pt)
*
|
2005-11-08 |
2011-08-30 |
Ranbaxy Lab Ltd |
processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
|
|
US20070238716A1
(en)
*
|
2006-03-14 |
2007-10-11 |
Murthy Ayanampudi S R |
Statin stabilizing dosage formulations
|
|
PL2001469T3
(pl)
|
2006-03-16 |
2012-10-31 |
Metabolic Solutions Dev Co Llc |
Analogi tiazolidynodionu
|
|
MX356584B
(es)
|
2006-03-16 |
2018-06-05 |
Metabolic Solutions Dev Co |
Analogos de tiazolidindiona para el tratamiento de enfermedad mediada por inflamacion metabolica.
|
|
TW200811101A
(en)
*
|
2006-07-14 |
2008-03-01 |
Ranbaxy Lab Ltd |
Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof
|
|
CL2008000684A1
(es)
|
2007-03-09 |
2008-08-01 |
Indigene Pharmaceuticals Inc |
Composicion farmaceutica que comprende metformina r-(+) lipoato y un inhibidor de reductasa hmg-coa; formulacion de dosis unitaria; y uso en el tratamiento de una complicacion diabetica.
|
|
DK2068909T3
(da)
|
2007-03-30 |
2012-08-06 |
Ambrx Inc |
Modificerede FGF-21-polypeptider og anvendelse heraf
|
|
EP2431043A1
(en)
|
2007-05-23 |
2012-03-21 |
Amcol International Corporation |
Cholesterol-interacting layered phyllosilicates for suppressing gastrointestinal cholesterol absorption
|
|
WO2009038681A1
(en)
*
|
2007-09-14 |
2009-03-26 |
Metabolic Solutions Development Company |
Thiazolidinedione analogues for the treatment of hypertension
|
|
US8304441B2
(en)
|
2007-09-14 |
2012-11-06 |
Metabolic Solutions Development Company, Llc |
Thiazolidinedione analogues for the treatment of metabolic diseases
|
|
WO2010077101A2
(ko)
*
|
2008-12-30 |
2010-07-08 |
조선대학교산학협력단 |
신규한 티아졸리딘디온 유도체 및 그의 용도
|
|
NZ620441A
(en)
|
2009-09-03 |
2015-08-28 |
Pfizer Vaccines Llc |
Pcsk9 vaccine
|
|
CA2780683A1
(en)
|
2009-11-13 |
2011-05-19 |
Toray Industries, Inc. |
Therapeutic or prophylactic combination of a prostaglandin i2 and a thiazolidine for diabetes
|
|
AU2010340055B2
(en)
|
2009-12-15 |
2014-07-24 |
Cirius Therapeutics, Inc. |
PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases
|
|
WO2011091134A2
(en)
|
2010-01-22 |
2011-07-28 |
Dana-Farber Cancer Institute, Inc. |
Compositions,kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
|
|
CN102946860A
(zh)
*
|
2010-04-21 |
2013-02-27 |
新陈代谢解决方案开发公司 |
噻唑烷二酮类似物
|
|
US20120094959A1
(en)
|
2010-10-19 |
2012-04-19 |
Bonnie Blazer-Yost |
Treatment of cystic diseases
|
|
WO2012131504A1
(en)
|
2011-03-02 |
2012-10-04 |
Pfizer Inc. |
Pcsk9 vaccine
|
|
US9623015B2
(en)
|
2012-11-05 |
2017-04-18 |
Commissariat À L'energie Atomique Et Aux Energies Alternatives (Cea) |
Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a STAT5 antagonist, preferably a thiazolidinedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse
|
|
EP3094328B1
(en)
|
2014-01-15 |
2020-08-19 |
Poxel SA |
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
|
|
WO2015123291A1
(en)
|
2014-02-11 |
2015-08-20 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Pcsk9 vaccine and methods of using the same
|
|
EA036697B1
(ru)
|
2014-10-24 |
2020-12-09 |
Бристол-Майерс Сквибб Компани |
Модифицированные полипептиды fgf-21 и их применение
|
|
WO2016071727A1
(en)
|
2014-11-04 |
2016-05-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the prevention and the treatment of rapidly progressive glomerulonephritis
|
|
JP6940411B2
(ja)
|
2015-03-13 |
2021-09-29 |
エスペリオン・セラピューティクス・インコーポレイテッドEsperion Therapeutics, Inc. |
Etc1002及びエゼチミブを含む固定用量組合せ物及び製剤並びに心血管疾患を処置するか又は心血管疾患のリスクを低減させる方法
|
|
MA41793A
(fr)
|
2015-03-16 |
2018-01-23 |
Esperion Therapeutics Inc |
Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
|
|
CN115429784A
(zh)
|
2019-06-21 |
2022-12-06 |
艾斯柏伦治疗公司 |
制备贝派地酸及其组合物的方法
|